These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29493453)

  • 1. Therapeutic Nanotechnology for Bone Infection Treatment - State of the Art.
    Guo P; Xue HY; Wong HL
    Curr Drug Deliv; 2018; 15(7):941-952. PubMed ID: 29493453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors pivotal for designing of nanoantimicrobials: an exposition.
    Jamil B; Imran M
    Crit Rev Microbiol; 2018 Feb; 44(1):79-94. PubMed ID: 28421881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growing role of nanotechnology in combating infectious disease.
    Blecher K; Nasir A; Friedman A
    Virulence; 2011; 2(5):395-401. PubMed ID: 21921677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge.
    Santos-Ferreira I; Bettencourt A; Almeida AJ
    Nanomedicine (Lond); 2015; 10(20):3131-45. PubMed ID: 26446355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in nanotechnology for eradicating bacterial biofilm.
    Sahli C; Moya SE; Lomas JS; Gravier-Pelletier C; Briandet R; Hémadi M
    Theranostics; 2022; 12(5):2383-2405. PubMed ID: 35265216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity interactions drive post-implantation drug filling, even in the presence of bacterial biofilm.
    Cyphert EL; Zuckerman ST; Korley JN; von Recum HA
    Acta Biomater; 2017 Jul; 57():95-102. PubMed ID: 28414173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How nanotechnology-enabled concepts could contribute to the prevention, diagnosis and therapy of bacterial infections.
    Herrmann IK
    Crit Care; 2015 May; 19(1):239. PubMed ID: 26025027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Assessment of Nanomaterials for Antimicrobial Applications.
    Ali A; Ovais M; Cui X; Rui Y; Chen C
    Chem Res Toxicol; 2020 May; 33(5):1082-1109. PubMed ID: 32302095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defensin-based anti-infective strategies.
    Wilmes M; Sahl HG
    Int J Med Microbiol; 2014 Jan; 304(1):93-9. PubMed ID: 24119539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations.
    Henry SL; Galloway KP
    Clin Pharmacokinet; 1995 Jul; 29(1):36-45. PubMed ID: 7586897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of nanodrug carriers in the prevention and treatment of infection around orthopedic prosthesis].
    Pan Z; Wang Y; Li J; Chen J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Oct; 36(5):862-869. PubMed ID: 31631637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?].
    Lebeaux D; Ghigo JM
    Med Sci (Paris); 2012; 28(8-9):727-39. PubMed ID: 22920875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: A review.
    Kumar MS; Das AP
    Adv Colloid Interface Sci; 2017 Nov; 249():53-65. PubMed ID: 28668171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial stewardship: a collaborative partnership between infection preventionists and health care epidemiologists.
    Moody J; Cosgrove SE; Olmsted R; Septimus E; Aureden K; Oriola S; Patel GW; Trivedi KK
    Am J Infect Control; 2012 Mar; 40(2):94-5. PubMed ID: 22381221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Delivery Based on Nanotechnology for Target Bone Disease.
    Yang X; Chen S; Liu X; Yu M; Liu X
    Curr Drug Deliv; 2019; 16(9):782-792. PubMed ID: 31530265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable chitosan nanoparticles in drug delivery for infectious disease.
    Landriscina A; Rosen J; Friedman AJ
    Nanomedicine (Lond); 2015 May; 10(10):1609-19. PubMed ID: 26008195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.